CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-10-24 | Friedman Mark Louis VP,Regulatory & Quality | Option exercise · Employee Stock Option (right to purchase) | −40,000 | 0 | ||
| 2017-10-24 | Friedman Mark Louis VP,Regulatory & Quality | Option exercise · Employee Stock Option (right to purchase) | −1,250 | 3,750 | ||
| 2017-10-24 | Friedman Mark Louis VP,Regulatory & Quality | Option exercise · Employee Stock Option (right to purchase) | −5,313 | 3,187 | ||
| 2017-10-24 | Friedman Mark Louis VP,Regulatory & Quality | Option exercise · Employee Stock Option (right to purchase) | −4,375 | 625 | ||
| 2017-10-24 | Friedman Mark Louis VP,Regulatory & Quality | Option exercise · Employee Stock Option (right to purchase) | −16,829 | 0 | ||
| 2017-09-25 | Freitag Gregory Gene General Counsel & SVP BD | Option exercise | +10,000 | $2.74 | $27K | 101,116 |
| 2017-09-25 | Freitag Gregory Gene General Counsel & SVP BD | Shares withheld for taxes | −1,450 | $18.90 | $27K | 99,666 |
| 2017-09-25 | Freitag Gregory Gene General Counsel & SVP BD | Option exercise · Employee Stock Option (right to purchase) | −10,000 | 36,000 | ||
| 2017-09-11 | Rudelius Robert James Director | Sale | −16,143 | $18.00 | $291K | 23,273 |
| 2017-09-08 | Rudelius Robert James Director | Option exercise | +20,000 | $3.50 | $70K | 43,273 |
| 2017-09-08 | Rudelius Robert James Director | Shares withheld for taxes | −3,857 | $18.15 | $70K | 39,416 |
| 2017-09-08 | Rudelius Robert James Director | Option exercise · Director Stock Option (right to purchase) | −20,000 | 0 | ||
| 2017-08-27 | Freitag Gregory Gene General Counsel & SVP BD | Option exercise | +23,000 | $2.74 | $63K | 94,901 |
| 2017-08-27 | Freitag Gregory Gene General Counsel & SVP BD | Shares withheld for taxes | −3,785 | $16.65 | $63K | 91,116 |
| 2017-08-27 | Freitag Gregory Gene General Counsel & SVP BD | Option exercise · Employee Stock Option (right to purchase) | −23,000 | 46,000 | ||
| 2017-08-02 | MCCARREY SHAWN F SVP Sales | Grant or award | +7,150 | 41,550 | ||
| 2017-08-02 | MCCARREY SHAWN F SVP Sales | Shares withheld for taxes | −2,383 | $15.15 | $36K | 39,167 |
| 2017-07-17 | Gingrich Jon S. Chief Commercial Officer | Grant or award · Employee Stock Option (right to purchase) | +115,000 | 115,000 | ||
| 2017-06-01 | NEELS GUIDO J Director | Grant or award · Stock Option (right to purchase) | +15,000 | 15,000 | ||
| 2017-06-01 | Wendell Amy McBride Director | Grant or award · Stock Option (right to purchase) | +15,000 | 15,000 |
Page 58 of 61 · 1,220 trades